Antheia Appoints Eric d'Esparbes as Chief Financial Officer

d'Esparbes to lead Antheia's financial strategy as the company continues its global expansion
and commercialization

MENLO PARK, Calif., Oct. 21, 2025 /PRNewswire/ -- Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the appointment of Eric d'Esparbes as Chief Financial Officer. d'Esparbes will oversee Antheia's financial strategy and operations as the company advances its next phase of commercialization and unlocks its U.S. manufacturing capabilities. His appointment comes at a critical point in Antheia's trajectory, following the company's $56 million Series C fundraise in June of this year and the launch of its first commercial product in 2024.

Read more at prnewswire.com